GLSI

GLSI R&D Expenses

$15.81MTTM · USD

Period ending:

GLSI FY R&D ExpensesUSD
GLSI FY R&D Expenses2017-12-31: $1.22M2018-12-31: $1.27M2019-12-31: $2.61M2020-12-31: $1.06M2021-12-31: $3.56M2022-12-31: $6.48M2023-12-31: $7.70M2024-12-31: $15.48M2025-12-31: $17.22M$17.22M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GLSI r&d expenses history

Research and development spending. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Greenwich Lifesciences Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
17,220,401
15,480,217
7,698,622
6,475,668
3,559,515
1,057,606
2,606,420
1,270,016
1,223,051

Compare r&d expenses

All GLSI financial metrics · GLSI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.